![James Neal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Neal
Direktor/Vorstandsmitglied bei
PROCESSA PHARMACEUTICALS, INC.
Vermögen: 2 506 $ am 31.05.2025
Profil
Herr James R. Neal ist Chairman bei Palisade Bio, Inc. und Chief Executive Officer & Director bei XOMA Corp. sowie Chief Executive Officer bei XOMA (US) LLC. Er ist Mitglied des Board of Directors bei Leading Biosciences, Inc. und XOMA Corp. Herr Neal war zuvor als President & Chief Executive Officer bei Entelos, Inc. beschäftigt, als Chief Executive Officer & Director bei Iconix Biosciences, Inc. und als EVP-Sales, Marketing & Business Development bei Incyte Genomics Inc. /Micoarray Operations/, ein General Manager von The Solaris Group, ein Partner von Eli Lilly & Co. Ltd, ein Partner bei GlaxoSmithKline Pharmaceuticals SA (Belgien), ein Principal bei Monsanto Co. und ein Chief Executive Officer bei der US Food & Drug Administration. Er erhielt seinen Bachelor-Abschluss von der University of Manitoba, einen Graduate-Abschluss von der University of Manitoba und einen MBA von der Washington University in St. Louis.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.04.2026 | 818 ( 0,03 % ) | 2 094 $ | 31.05.2026 | |
AKARI THERAPEUTICS PLC 0,08 % | 31.12.2025 | 41 144 000 ( 0,08 % ) | 411 $ | 31.05.2025 |
Aktive Positionen von James Neal
| Unternehmen | Position | Beginn |
|---|---|---|
| MONTEREY INNOVATION ACQUISITION CORP. | Direktor/Vorstandsmitglied | 09.03.2023 |
| PROCESSA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 16.07.2022 |
| AKARI THERAPEUTICS, PLC | Direktor/Vorstandsmitglied | 13.11.2024 |
XOMA (US) LLC
 XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von James Neal
| Unternehmen | Position | Ende |
|---|---|---|
| PEAK BIO, INC. | Direktor/Vorstandsmitglied | 14.11.2024 |
| PALISADE BIO, INC. | Vorsitzender | 09.02.2024 |
| XOMA ROYALTY CORPORATION | Vorstandsvorsitzender | 01.01.2023 |
| PALISADE BIO, INC. | Vorsitzender | 29.04.2021 |
Entelos, Inc.
 Entelos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial partner that supports drug research and development teams | Vorstandsvorsitzender | 11.09.2009 |
Ausbildung von James Neal
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
19
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 19 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Monsanto Co.
 Monsanto Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company controlling insects and weeds & manufactures seeds and genomics | Commercial Services |
Iconix Biosciences, Inc.
 Iconix Biosciences, Inc. BiotechnologyHealth Technology Provides toxicogenomics products and services | Health Technology |
Entelos, Inc.
Entelos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial partner that supports drug research and development teams | Commercial Services |
The Solaris Group
 The Solaris Group Chemicals: AgriculturalProcess Industries Manufactures plant food | Process Industries |
Incyte Genomics Inc. /Micoarray Operations/
 Incyte Genomics Inc. /Micoarray Operations/ Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical drug discovery and development services | Commercial Services |
University of Manitoba
 University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Manufactures biotherapeutic products | Health Technology |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Health Technology |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Processa Pharmaceuticals, Inc.
 Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Leading Biosciences, Inc.
 Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Commercial Services |
Palisade Bio, Inc.
 Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
Monterey Innovation Acquisition Corp.
 Monterey Innovation Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Peak Bio, Inc.
 Peak Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics to treat oncology and inflammatory diseases | Health Technology |
